chr10-103101176-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001351169.2(NT5C2):​c.481+59T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.014 in 1,409,854 control chromosomes in the GnomAD database, including 187 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.010 ( 12 hom., cov: 32)
Exomes 𝑓: 0.014 ( 175 hom. )

Consequence

NT5C2
NM_001351169.2 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 3.02

Publications

3 publications found
Variant links:
Genes affected
NT5C2 (HGNC:8022): (5'-nucleotidase, cytosolic II) This gene encodes a hydrolase that serves as an important role in cellular purine metabolism by acting primarily on inosine 5'-monophosphate and other purine nucleotides. [provided by RefSeq, Oct 2011]
NT5C2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 45
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 10-103101176-A-G is Benign according to our data. Variant chr10-103101176-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 1213606.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0101 (1528/151900) while in subpopulation NFE AF = 0.0168 (1146/68024). AF 95% confidence interval is 0.016. There are 12 homozygotes in GnomAd4. There are 704 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NT5C2NM_001351169.2 linkc.481+59T>C intron_variant Intron 7 of 18 ENST00000404739.8 NP_001338098.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NT5C2ENST00000404739.8 linkc.481+59T>C intron_variant Intron 7 of 18 1 NM_001351169.2 ENSP00000383960.3 P49902-1

Frequencies

GnomAD3 genomes
AF:
0.0101
AC:
1530
AN:
151786
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00324
Gnomad AMI
AF:
0.0186
Gnomad AMR
AF:
0.00426
Gnomad ASJ
AF:
0.0121
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00787
Gnomad FIN
AF:
0.00678
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.0169
Gnomad OTH
AF:
0.00621
GnomAD4 exome
AF:
0.0145
AC:
18220
AN:
1257954
Hom.:
175
Cov.:
18
AF XY:
0.0143
AC XY:
9076
AN XY:
636770
show subpopulations
African (AFR)
AF:
0.00236
AC:
69
AN:
29184
American (AMR)
AF:
0.00427
AC:
188
AN:
44026
Ashkenazi Jewish (ASJ)
AF:
0.0132
AC:
328
AN:
24854
East Asian (EAS)
AF:
0.0000258
AC:
1
AN:
38688
South Asian (SAS)
AF:
0.00847
AC:
693
AN:
81810
European-Finnish (FIN)
AF:
0.00940
AC:
501
AN:
53276
Middle Eastern (MID)
AF:
0.00985
AC:
53
AN:
5382
European-Non Finnish (NFE)
AF:
0.0170
AC:
15742
AN:
927210
Other (OTH)
AF:
0.0121
AC:
645
AN:
53524
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
914
1828
2743
3657
4571
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
556
1112
1668
2224
2780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0101
AC:
1528
AN:
151900
Hom.:
12
Cov.:
32
AF XY:
0.00948
AC XY:
704
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.00323
AC:
133
AN:
41174
American (AMR)
AF:
0.00425
AC:
65
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
42
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00767
AC:
37
AN:
4824
European-Finnish (FIN)
AF:
0.00678
AC:
72
AN:
10616
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.0168
AC:
1146
AN:
68024
Other (OTH)
AF:
0.00615
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
77
154
230
307
384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0143
Hom.:
4
Bravo
AF:
0.00960
Asia WGS
AF:
0.00375
AC:
13
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Aug 15, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
17
DANN
Benign
0.71
PhyloP100
3.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41287482; hg19: chr10-104860933; API